Brecht Vanbillemont

Brecht Vanbillemont is a Senior Scientist at Coriolis Pharma since November 2020, where responsibilities include managing the full lifecycle of over ten contract research organization development studies focused on viruses, mRNA, high concentration antibodies, and peptide formulations. Prior experience includes serving as a Scientist at FONDS VOOR WETENSCHAPPELIJK ONDERZOEK - VLAANDEREN FWO ASBL from January 2017 to October 2020, where Brecht acquired funding for a PhD project involving innovative research with potential economic applications. Brecht's academic background includes a PhD in Pharmaceutical Sciences from Ghent University and positions as a PhD researcher and visiting research scholar, along with a traineeship at The Janssen Pharmaceutical Companies of Johnson & Johnson. Brecht holds several degrees in Pharmaceutical Sciences, Industrial Pharmacy, and Drug Development from Ghent University and completed secondary education at Onze Lieve Vrouwecollege Oostende.